It has been reported not only in cancer but also in diseases such as another literature by Shen et al. [15] established that ALKBH5 selectively augments the incidence of acute myeloid leukemia (AML) and the self-renewal of carcinoma stem cells. Here, ALKBH5 is linked to acute myeloid leukemia.